2027 Summer Intern Engineering, Design, & Construction
Regeneron Pharmaceuticals
Summary
Regeneron is currently seeking a 2027 Intern in PMO, Engineering, Design & Construction supporting major capital projects and campus expansion initiatives.
Job description
When & where
Location: Tarrytown, NY
Timeframe: Our internship positions are full-time and onsite from May/June-August
What you'll do
- Partner with project managers, engineers, architects, and construction teams.
- Assist with project planning, scheduling, cost tracking, and progress monitoring.
- Support coordination among contractors, vendors, and stakeholders.
- Help ensure compliance with safety requirements and project standards.
- Gain exposure to large-scale capital construction projects.
Relevant majors: Construction Management, Civil Engineering, Mechanical Engineering, Electrical Engineering, Architecture, Engineering Management
Let's find out if we're a fit
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred.
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position).
- Cumulative GPA of 3.0 or higher preferred.
Requirements
- Must be enrolled in, or accepted to, an academic program pursuing an Undergraduate or Graduate degree (and be returning to school the semester following the position or graduating after the position)
- Relevant majors: Construction Management, Civil Engineering, Mechanical Engineering, Electrical Engineering, Architecture, Engineering Management
- Demonstrated leadership in areas such as campus activities, clubs, sports, current or previous work, or within the community preferred
- Cumulative GPA of 3.0 or higher preferred
Benefits
- Annual bonuses
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.